Evaluation of a novel herbal antiseptic formulation â?? SEPIL for the treatment of chronic limb ulcers and pressure ulcers: A randomized, Double-blind, Placebo-Controlled Trial

Dr Vikas Gautam0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Adult men and women aged 18 years or older
•2. A diagnosis of diabetic ulcer or limb ulcer (arterial or venous ulcer) or decubitus (pressure) ulcer; and
•3. Wound size <10 cm in diameter (preferably).

•1. Infection to be cured with antibiotics
•2. Deep ulcer reaching bone tissue
•3. Severe edema around skin ulcer,
•4. Patients with severe heart failure, severe liver, kidney, and blood dysfunction,
•5. Poor general condition due to severe systemic infection,
•6. Poor control of hyperglycemia (HbA1c â?§9.0%)
•7. Pregnant women, and men or women who disagree to avoid pregnancy during clinical trial period
•8. Surgical procedure for skin ulcer from 2 weeks before SEPIL or placebo treatment,
•9. Participation in other clinical trial from 12 weeks before entry,
•10. Judgment as an inappropriate patient by principle investigator.

发起方

Dr Vikas Gautam